The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
- PMID: 36769192
- PMCID: PMC9917482
- DOI: 10.3390/ijms24032874
The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
Abstract
Pleural mesothelioma (PM) is a cancer where epithelioid, biphasic and sarcomatoid histotypes are observed. Sarcomatoid PM is characterized by mesenchymal features. Multi-omics have been used to characterize the epithelial-to-mesenchymal (EMT) phenotype at the molecular level. We contribute to this effort by including the analysis of RNA editing. We extracted samples with the highest vs. lowest Epithelial score from two PM cohorts and observed increased RNA editing in introns and decreased RNA editing in 3'UTR upon EMT. The same was observed in primary PM primary cultures stratified by transcriptomics analysis into two groups, one of them enriched with mesenchymal features. Our data demonstrate that, as has been observed in other cancer types, RNA editing associates to EMT phenotype in PM.
Keywords: RNA editing; epithelial-to-mesenchymal transition; pleural mesothelioma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- Carbone M., Adusumilli P.S., Alexander H.R., Jr., Baas P., Bardelli F., Bononi A., Bueno R., Felley-Bosco E., Galateau-Salle F., Jablons D., et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J. Clin. 2019;69:402–429. doi: 10.3322/caac.21572. - DOI - PMC - PubMed
-
- Sauter J.L., Dacic S., Galateau-Salle F., Attanoos R.L., Butnor K.J., Churg A., Husain A.N., Kadota K., Khoor A., Nicholson A.G., et al. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification. J. Thorac. Oncol. 2022;17:608–622. doi: 10.1016/j.jtho.2021.12.014. - DOI - PubMed
-
- Bueno R., Stawiski E.W., Goldstein L.D., Durinck S., De Rienzo A., Modrusan Z., Gnad F., Nguyen T.T., Jaiswal B.S., Chirieac L.R., et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat. Genet. 2016;48:407–416. doi: 10.1038/ng.3520. - DOI - PubMed
-
- de Reynies A., Jaurand M.C., Renier A., Couchy G., Hysi I., Elarouci N., Galateau-Salle F., Copin M.C., Hofman P., Cazes A., et al. Molecular classification of malignant pleural mesothelioma: Identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin. Cancer Res. 2014;20:1323–1334. doi: 10.1158/1078-0432.CCR-13-2429. - DOI - PubMed
-
- Hmeljak J., Sanchez-Vega F., Hoadley K.A., Shih J., Stewart C., Heiman D.I., Tarpey P., Danilova L., Drill E., Gibb E.A., et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discov. 2018;8:1548–1565. doi: 10.1158/2159-8290.CD-18-0804. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical